Suppr超能文献

肝纤维化。发病机制与治疗原则。

Hepatic fibrosis. Pathogenesis and principles of therapy.

作者信息

Albanis E, Friedman S L

机构信息

Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York, USA.

出版信息

Clin Liver Dis. 2001 May;5(2):315-34, v-vi. doi: 10.1016/s1089-3261(05)70168-9.

Abstract

There has been great progress made in our understanding of the cellular mechanisms of hepatic fibrosis. The recognition that the hepatic stellate cell, (formerly know as lipocyte, Ito, or fat-storing cell), played a central role in the fibrotic response was key to our understanding. Stellate cells undergo a process known as activation, in response to any insult. Activation is a broad phenotypic response, characterized by distinct functional changes in proliferation, fibrogenesis, contractility, cytokine secretion, and matrix degradation. Insights gained into the molecular regulations of stellate cell activation may lead to new antifibrotic therapies, which may reduce morbidity and mortality in patients with chronic liver injury.

摘要

我们对肝纤维化细胞机制的理解取得了巨大进展。认识到肝星状细胞(以前称为脂肪细胞、伊托细胞或贮脂细胞)在纤维化反应中起核心作用是我们理解的关键。星状细胞会对任何损伤产生一种称为激活的过程。激活是一种广泛的表型反应,其特征是在增殖、纤维生成、收缩性、细胞因子分泌和基质降解方面有明显的功能变化。对星状细胞激活分子调控的深入了解可能会带来新的抗纤维化疗法,这可能会降低慢性肝损伤患者的发病率和死亡率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验